CVC buys into M&G’s $1bn-plus managed fund deal
The deal sees a portfolio of private equity interests move into a new vehicle run by M&G.
Adams Street and Lexington lead Vitruvian’s $1bn+ fundraise
The vehicle, named Andantino AV, has some CV components and houses Vitruvian’s ownership in four assets, Secondaries Investor understands.
Florida SBA explores multibillion-dollar portfolio sale
The pension has been actively pursuing opportunities in the secondaries market over the past few years.
CVC emerges as lead in Cerberus’s large CV for SubCom
The deal marks the latest $1bn-plus CV the Luxembourg-headquartered firm has been involved in over the last several months.
Hayfin anchors €155m Spanish healthcare CV
Spanish manager Alantra has closed a continuation vehicle for its portfolio company Health in Code, with 25% of the capital earmarked for follow on investment.
Coller leads on $1.3bn Ares credit continuation vehicle
The firm, which EQT recently agreed to acquire, has led on multiple multibillion-dollar credit CVs over the past several months.
DW Healthcare runs process to extend hold over animal pharmaceuticals business
While some participants have described secondaries activity as somewhat subdued in the early part of the year, numerous deals continue to work through their processes that had been launched last year.
Lexington and Partners Group among buyers on CalPERS’ latest LP-led sale
The original size of the portfolio CalPERS brought to the market is understood to be between $2.3bn and $3bn.
Eurazeo and Pantheon complete €480m credit CV
The deal is the second between the two firms to provide liquidity to Eurazeo’s LPs while maintaining continuity for borrowers.
Managers increasingly look to fill secondaries gaps with GP acquisitions – Campbell Lutyens
As more high-profile secondaries managers get snapped up, there is a 'scarcity value' in the strategy, managing director Hannah Gore-Randall tells Secondaries Investor.